<DOC>
	<DOCNO>NCT01808469</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability distribution elimination novel therapeutic drug administer Healthy Volunteers . In addition effect inflammatory parameter measure presence absence lipopolysaccharide stimulation .</brief_summary>
	<brief_title>First Human Study Anti-Toll-like Receptor 4 ( TLR4 ) Monoclonal Antibody ( NI-0101 ) Adult Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Healthy adult 18 40 year old ( inclusive ) body mass index ( BMI ) 18 30 kg/m2 ( inclusive ) , able adhere study protocol requirement sign informed consent . Any abnormal past present clinically relevant medical history relevant abnormal laboratory parameter screen prevent consider volunteer healthy study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>